for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Organogenesis Holdings Inc

ORGO.OQ

Latest Trade

4.21USD

Change

0.24(+6.05%)

Volume

109,383

Today's Range

3.95

 - 

4.31

52 Week Range

2.49

 - 

8.33

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
3.97
Open
4.00
Volume
109,383
3M AVG Volume
3.15
Today's High
4.31
Today's Low
3.95
52 Week High
8.33
52 Week Low
2.49
Shares Out (MIL)
105.42
Market Cap (MIL)
418.51
Forward P/E
--
Dividend (Yield %)
--

Next Event

Q3 2020 Organogenesis Holdings Inc Earnings Release

Latest Developments

More

Organogenesis Holdings Inc. Reports Preliminary Financial Results For Third Quarter 2020

Organogenesis Holdings Inc. Announces Management Change

Organogenesis Holdings Reports Q2 Loss Per Share $0.05

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Organogenesis Holdings Inc

Organogenesis Holdings Inc., formerly Avista Healthcare Public Acquisition Corp, is a regenerative medicine company. The Company focuses on the development, manufacture and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. It also provides integrated healing solutions that substantially improve medical outcomes. The Company’s advanced wound care and surgical & sports medicine products include PuraPly, Antimicrobial (PuraPlyAM), PuraPly, Affinity, NuShield, Apligraf and Dermagraft. The Company is offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. The Company’s comprehensive portfolio is designed to treat a variety of patients with repair and regenerative needs.

Industry

Biotechnology & Drugs

Contact Info

85 Dan Rd

CANTON, MA

02021-2810

United States

+1.781.5750775

https://investors.organogenesis.com

Executive Leadership

Gary S. Gillheeney

President, Chief Executive Officer, Director

Henry Hagopian

Interim Chief Financial Officer, Vice President - Finance, Treasurer

Patrick Bilbo

Chief Operating Officer

Lori Freedman

Vice President, General Counsel

Antonio S. Montecalvo

Vice President - Health Policy and Contracting

Key Stats

1.25 mean rating - 4 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2019

0.3K

2020(E)

0.3K
EPS (USD)

2019

-0.440

2020(E)

-0.388
Price To Earnings (TTM)
--
Price To Sales (TTM)
1.55
Price To Book (MRQ)
11.71
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
322.55
LT Debt To Equity (MRQ)
294.60
Return on Investment (TTM)
-27.32
Return on Equity (TTM)
-19.04

Latest News

Latest News

U.S. RESEARCH ROUNDUP-Digital Realty Trust, Pilgrims Pride, Terraform Power

Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Digital Realty Trust, Pilgrims Pride and Terraform Power, on Tuesday. HIGHLIGHTS * Digital Realty Trust Inc : Citigroup cuts to neutral from buy * Pilgrims...

BRIEF-Organogenesis Holdings Posts Quarterly Loss Per Share Of $0.04

* . REPORTS FOURTH QUARTER AND FISCAL YEAR 2019 FINANCIAL RESULTS; INTRODUCES FISCAL YEAR 2020 REVENUE GUIDANCE

IFR US ECM Weekly Wrap-up

WEEKLY TOTAL $9.6bn – IPO $993m – ABB/BLOCK $6.3bn – FOLLOW-ON $1.65bn – CB $705m Monday

IFR US ECM Calendar

Alpine Income Property Trust (US, REIT) – $142.5m IPO. 7.5m shares (100% prim) at $19.00 versus $19-21 marketing. RJ, BAIRD, BRILEY, BMO, JMS, DAD.

IFR US ECM Calendar

Alpine Income Property Trust (US, REIT) – $157.5m IPO. 7.5m shares (100% prim) at $19.00 versus $19-21 marketing. RJ, BAIRD, BRILEY, BMO, JMS, DAD. NYSE “PINE”.

IFR US ECM Calendar

Canaan (China, cryptocurrency) – $90m IPO. 10m ADSs (100% prim) at $9.00 versus $9-$11 marketing. CITI, CREN, CMBI. Nasdaq "CAN". 14 investors indicated an interest in 5% of the ADSs.

IFR US ECM Calendar

Canaan (China, cryptocurrency) – $90m IPO. 10m ADSs (100% prim) at $9.00 versus $9-$11 marketing. CITI, CREN, CMBI. Nasdaq "CAN". 14 investors indicated an interest in 5% of the ADSs.

IFR US ECM Calendar

Amplitude Healthcare Acquisition (US, SPAC) – $100m IPO. 10m units (100% prim) at $10.00. Each unit comprises one share and one-half of a warrant. BMO, SVBL.

IFR US ECM Calendar

Amplitude Healthcare Acquisition (US, SPAC) – $100m IPO. 10m units (100% prim) at $10.00. Each unit comprises one share and one-half of a warrant. BMO, SVBL.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up